| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | uridine | 1000 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | uridine | 1009.717 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | uridine | 1406.47 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | uridine | 1485.899 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | uridine | 2391.828 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | uridine | 2853.941 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | uridine | 2896.383 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | uridine | 2902.916 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | uridine | 3294.846 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | uridine | 3520.895 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | uridine | 3975.612 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | uridine | 4741.688 | Peak area (top) | ML162 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|